Risk of contrast induced nephropathy in the critically ill

A prospective, case matched study

Cynthia M. Cely, Roland Schein, Andrew Quartin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Introduction: Computerized tomography is frequently employed in the critically ill, often using intravenous radiocontrast material. Many of these patients have clinical features that are considered risk factors for contrast induced nephropathy, but are simultaneously at risk for renal injury from other factors related to their acute illnesses. The attributable risk for renal dysfunction from radiocontrast exposure has not been well quantified in this population.Methods: A prospective matched cohort study was conducted of patients scanned with or without radiocontrast enhancement while receiving intensive care in a Veterans Affairs Medical Center. Patients were matched for pre-scan measured creatinine clearance, diabetes, mechanical ventilation, and vasopressor use. Measured clearance was followed for three days after scanning. Evolution of nephropathy, as determined by change in measured clearance, was compared within matched pairs.Results: Fifty-three pairs of patients satisfied matching criteria. Unmatched characteristics were similar among the pairs, including serum creatinine variability during the week preceding scanning (67 ± 85% among contrast recipients, 63 ± 62% among others) and clinical risk factors for renal failure. In 29 pairs, pre-scan measured clearances were less than 60 mL/minute/1.73 m 2. Following scanning, measured clearance declined by at least 33% in 14 contrast and 19 non-contrast patients (95% confidence interval for contrast associated difference in nephropathy rates -27% to 9%), while a 50% reduction in clearance persisted three days after scanning in three contrast and nine non-contrast patients (95% confidence interval for difference in rates -25% to 2%).Conclusions: Among established intensive care unit patients declines in glomerular filtration following contrast-enhanced scanning are common, but these changes are far more likely to be attributable to factors other than the contrast exposure itself. The upper bound for the incidence of contrast induced renal injury lasting even three days was 2% in the population studied.

Original languageEnglish
Article numberR67
JournalCritical Care
Volume16
Issue number2
DOIs
StatePublished - Apr 25 2012

Fingerprint

Critical Illness
Kidney
Creatinine
Confidence Intervals
Wounds and Injuries
Veterans
Critical Care
Artificial Respiration
Population
Renal Insufficiency
Intensive Care Units
Cohort Studies
Tomography
Incidence
Serum

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Risk of contrast induced nephropathy in the critically ill : A prospective, case matched study. / Cely, Cynthia M.; Schein, Roland; Quartin, Andrew.

In: Critical Care, Vol. 16, No. 2, R67, 25.04.2012.

Research output: Contribution to journalArticle

@article{5af9e8ff3cb0422a89acc567ef11e127,
title = "Risk of contrast induced nephropathy in the critically ill: A prospective, case matched study",
abstract = "Introduction: Computerized tomography is frequently employed in the critically ill, often using intravenous radiocontrast material. Many of these patients have clinical features that are considered risk factors for contrast induced nephropathy, but are simultaneously at risk for renal injury from other factors related to their acute illnesses. The attributable risk for renal dysfunction from radiocontrast exposure has not been well quantified in this population.Methods: A prospective matched cohort study was conducted of patients scanned with or without radiocontrast enhancement while receiving intensive care in a Veterans Affairs Medical Center. Patients were matched for pre-scan measured creatinine clearance, diabetes, mechanical ventilation, and vasopressor use. Measured clearance was followed for three days after scanning. Evolution of nephropathy, as determined by change in measured clearance, was compared within matched pairs.Results: Fifty-three pairs of patients satisfied matching criteria. Unmatched characteristics were similar among the pairs, including serum creatinine variability during the week preceding scanning (67 ± 85{\%} among contrast recipients, 63 ± 62{\%} among others) and clinical risk factors for renal failure. In 29 pairs, pre-scan measured clearances were less than 60 mL/minute/1.73 m 2. Following scanning, measured clearance declined by at least 33{\%} in 14 contrast and 19 non-contrast patients (95{\%} confidence interval for contrast associated difference in nephropathy rates -27{\%} to 9{\%}), while a 50{\%} reduction in clearance persisted three days after scanning in three contrast and nine non-contrast patients (95{\%} confidence interval for difference in rates -25{\%} to 2{\%}).Conclusions: Among established intensive care unit patients declines in glomerular filtration following contrast-enhanced scanning are common, but these changes are far more likely to be attributable to factors other than the contrast exposure itself. The upper bound for the incidence of contrast induced renal injury lasting even three days was 2{\%} in the population studied.",
author = "Cely, {Cynthia M.} and Roland Schein and Andrew Quartin",
year = "2012",
month = "4",
day = "25",
doi = "10.1186/cc11317",
language = "English",
volume = "16",
journal = "Critical Care",
issn = "1466-609X",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Risk of contrast induced nephropathy in the critically ill

T2 - A prospective, case matched study

AU - Cely, Cynthia M.

AU - Schein, Roland

AU - Quartin, Andrew

PY - 2012/4/25

Y1 - 2012/4/25

N2 - Introduction: Computerized tomography is frequently employed in the critically ill, often using intravenous radiocontrast material. Many of these patients have clinical features that are considered risk factors for contrast induced nephropathy, but are simultaneously at risk for renal injury from other factors related to their acute illnesses. The attributable risk for renal dysfunction from radiocontrast exposure has not been well quantified in this population.Methods: A prospective matched cohort study was conducted of patients scanned with or without radiocontrast enhancement while receiving intensive care in a Veterans Affairs Medical Center. Patients were matched for pre-scan measured creatinine clearance, diabetes, mechanical ventilation, and vasopressor use. Measured clearance was followed for three days after scanning. Evolution of nephropathy, as determined by change in measured clearance, was compared within matched pairs.Results: Fifty-three pairs of patients satisfied matching criteria. Unmatched characteristics were similar among the pairs, including serum creatinine variability during the week preceding scanning (67 ± 85% among contrast recipients, 63 ± 62% among others) and clinical risk factors for renal failure. In 29 pairs, pre-scan measured clearances were less than 60 mL/minute/1.73 m 2. Following scanning, measured clearance declined by at least 33% in 14 contrast and 19 non-contrast patients (95% confidence interval for contrast associated difference in nephropathy rates -27% to 9%), while a 50% reduction in clearance persisted three days after scanning in three contrast and nine non-contrast patients (95% confidence interval for difference in rates -25% to 2%).Conclusions: Among established intensive care unit patients declines in glomerular filtration following contrast-enhanced scanning are common, but these changes are far more likely to be attributable to factors other than the contrast exposure itself. The upper bound for the incidence of contrast induced renal injury lasting even three days was 2% in the population studied.

AB - Introduction: Computerized tomography is frequently employed in the critically ill, often using intravenous radiocontrast material. Many of these patients have clinical features that are considered risk factors for contrast induced nephropathy, but are simultaneously at risk for renal injury from other factors related to their acute illnesses. The attributable risk for renal dysfunction from radiocontrast exposure has not been well quantified in this population.Methods: A prospective matched cohort study was conducted of patients scanned with or without radiocontrast enhancement while receiving intensive care in a Veterans Affairs Medical Center. Patients were matched for pre-scan measured creatinine clearance, diabetes, mechanical ventilation, and vasopressor use. Measured clearance was followed for three days after scanning. Evolution of nephropathy, as determined by change in measured clearance, was compared within matched pairs.Results: Fifty-three pairs of patients satisfied matching criteria. Unmatched characteristics were similar among the pairs, including serum creatinine variability during the week preceding scanning (67 ± 85% among contrast recipients, 63 ± 62% among others) and clinical risk factors for renal failure. In 29 pairs, pre-scan measured clearances were less than 60 mL/minute/1.73 m 2. Following scanning, measured clearance declined by at least 33% in 14 contrast and 19 non-contrast patients (95% confidence interval for contrast associated difference in nephropathy rates -27% to 9%), while a 50% reduction in clearance persisted three days after scanning in three contrast and nine non-contrast patients (95% confidence interval for difference in rates -25% to 2%).Conclusions: Among established intensive care unit patients declines in glomerular filtration following contrast-enhanced scanning are common, but these changes are far more likely to be attributable to factors other than the contrast exposure itself. The upper bound for the incidence of contrast induced renal injury lasting even three days was 2% in the population studied.

UR - http://www.scopus.com/inward/record.url?scp=84860209276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860209276&partnerID=8YFLogxK

U2 - 10.1186/cc11317

DO - 10.1186/cc11317

M3 - Article

VL - 16

JO - Critical Care

JF - Critical Care

SN - 1466-609X

IS - 2

M1 - R67

ER -